Immunocore shareholders back all AGM resolutions on poll vote

• Immunocore held its 2026 annual shareholder meeting on May 27, 2026, with all resolutions passed.
• Shareholders backed the reappointment of Siddharth Kaul, William Pao, and Kristine Peterson as directors.
• An advisory vote endorsed the named executive officers’ compensation.
• Deloitte LLP was ratified as U.S. independent registered public accounting firm for 2026, reappointed as U.K. statutory auditor, with audit-fee setting authority approved.
• Shareholders adopted the 2025 U.K. annual accounts and reports, approved the directors’ remuneration report, and authorized political donations and expenditure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunocore Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-022984), on May 27, 2026, and is solely responsible for the information contained therein.